GENERAL AND HIV-1-ASSOCIATED MORBIDITY IN A RURAL UGANDAN COMMUNITY

被引:22
|
作者
WAGNER, HU
KAMALI, A
NUNN, AJ
KENGEYAKAYONDO, JF
MULDER, DW
机构
[1] MRC UK RES PROGRAMME AIDS UGANDA,POB 49,ENTEBBE,UGANDA
[2] UGANDA VIRUS RES INST,ENTEBBE,UGANDA
关键词
HIV-1; MORBIDITY; RURAL POPULATION; UGANDA; AIDS CLINICAL CASE DEFINITION;
D O I
10.1097/00002030-199311000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: The AIDS epidemic in sub-Saharan Africa affects whole communities, adding to the. already high burden of morbidity. Reports of AIDS cases are usually from hospital attenders, often diagnosed using the World Health Organization (WHO) clinical case definition. Little is known about the extent of HIV-associated morbidity in the general population. The objectives of this study were to describe the prevalence of (1) markers of general morbidity and (2) the criteria of the WHO clinical case definition for AIDS and (3) to determine the association between these markers and HIV-1 serostatus in a rural Ugandan community. Methods: A survey was conducted among the adult population (aged greater-than-or-equal-to 13 years) of 15 neighbouring villages in Masaka District, south-west Uganda. The survey included medical history, physical examination and testing for HIV-1 antibodies. Results: The HIV-1 seroprevalence among 4175 out of 5278 (79%) eligible adults was 8.2%. Current health problems were reported by 57.6% of adults, with increased rates in HIV-1-positive subjects, women and older people. Five of the 10 most common complaints showed significant associations with HIV-1 status, as did reported genital ulcer and vaginal discharge. The crude HIV-1 attributable disease burden in the population was 1.2% for current illness, 4.3% for previous serious illness and 9.9% for illness leading to hospital admission. Overall, 11 (3.3%) of the HIV-1-positive and nine (0.2%) of the HIV-1-negative subjects had AIDS as defined by the clinical case definition. The positive and negative predictive values and specificity were 55.0, 92.0%, and 99.8%, respectively. Conclusions: Against a background of high general morbidity, we observed a relatively small population attribution of HIV-1-associated morbidity. The results indicate that the clinical AIDS case definition may provide a useful tool for population surveys.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 50 条
  • [1] HIV-1 INCIDENCE AND HIV-1-ASSOCIATED MORTALITY IN A RURAL UGANDAN POPULATION COHORT
    MULDER, DW
    NUNN, AJ
    WAGNER, HU
    KAMALI, A
    KENGEYAKAYONDO, JF
    [J]. AIDS, 1994, 8 (01) : 87 - 92
  • [2] 2-YEAR HIV-1-ASSOCIATED MORTALITY IN A UGANDAN RURAL-POPULATION
    MULDER, DW
    NUNN, AJ
    KAMALI, A
    NAKIYINGI, J
    WAGNER, HU
    KENGEYAKAYONDO, JF
    [J]. LANCET, 1994, 343 (8904): : 1021 - 1023
  • [3] HIV-1-associated encephalopathy and myelopathy
    Eggers, C
    [J]. NERVENARZT, 2000, 71 (08): : 677 - 684
  • [4] IMMUNOPATHOGENESIS OF HIV-1-ASSOCIATED CARDIOMYOPATHY
    HERSKOWITZ, A
    WILLOUGHBY, S
    WU, TC
    BESCHORNER, WE
    NEUMANN, DA
    ROSE, NR
    BAUGHMAN, KL
    ANSARI, AA
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 68 (02): : 234 - 241
  • [5] Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality
    Goodkin, K
    Wilkie, FL
    Concha, M
    Hinkin, CH
    Symes, S
    Baldewicz, TT
    Asthana, D
    Fujimura, RK
    Lee, D
    van Zuilen, MH
    Khamis, I
    Shapshak, P
    Eisdorfer, C
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 : S35 - S43
  • [6] Role for astrocytosis in HIV-1-associated dementia
    Vitkovic, L
    daCunha, A
    [J]. HIV AND DEMENTIA, 1995, 202 : 105 - 116
  • [7] RACE, A COFACTOR IN HIV-1-ASSOCIATED NEPHROPATHY
    BOURGOIGNIE, JJ
    ORTIZINTERIAN, C
    GREEN, DF
    ROTH, D
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (06) : 3899 - 3901
  • [8] HIV-1-ASSOCIATED THROMBOCYTOPENIA - THE ROLE OF SPLENECTOMY
    TYLER, DS
    SHAUNAK, S
    BARTLETT, JA
    IGLEHART, JD
    [J]. ANNALS OF SURGERY, 1990, 211 (02) : 211 - 217
  • [9] Neuroprotective strategies for HIV-1-associated neurologic disease
    Gelbard, HA
    [J]. NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 : 312 - 313
  • [10] Adjunctive treatment with etanercept in HIV-1-associated tuberculosis
    Wallis, RS
    Kyambadde, P
    Johnson, J
    Horter, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P110 - P110